Company

Dr. R. Pfleger GmbH

Dr. Pfleger is a medium-sized pharmaceutical company located in the city of Bamberg, Germany. The Dr. R. Pfleger GmbH was established in 1945 by Professor Robert Pfleger.

The company is entirely owned by the Doktor Robert Pfleger-Foundation, an organisation which directly supports basic medical research as well as charitable and social causes.

In co-operation with domestic and international pharmaceutical companies – Dr. Pfleger operates as both a licenser and a licensee – it has greatly expanded its range of products. The company now markets over 30 medicinal products, with a primary focus on urological, gynaecological, and dermatological indications.

Dr. Pfleger's main product is Spasmex®, an antimuscarinic drug used for treatment of unstable bladder, urge incontinence, and reflex incontinence. It is also used as an antispasmodic in gastroenterological indications. Spasmex® is registered or pre-registered in Germany, Argentina, Austria, the Baltic States, Brazil, Chile, the Czech Republic, Denmark, Finland, Greece, Israel, Italy, Japan, Luxembourg, Norway, Poland, Russia, the Slovak Republic, Singapore, Slovenia, Sweden, Switzerland, and Turkey.

Physician Assortment (selection)

- Anticholinergics: Trospium chloride
- Antimycotics: Nystatin, Fluconazole, Sertaconazole, Terbinafine
- Aromatase inhibitors: Anastrozole, Exemestane, Letrozole
- Urological drugs: Tamsulosin, Terazosin, Bicalutamide, Finasteride
- Antibiotics / Antiinfectives: Ciprofloxacin, Co-trimoxazole
- Antirheumatics: Diclofenac
- Antirheumatics / Analgesics: Ibuprofen
- Analgesics (with codeine)
- Sedatives: Nitrazepam
- Diuretics
- Beta blockers
- Platelet inhibitors
- Antihypertensives

Diese Webseite und die hier eingebundenen Dienste von Drittanbietern nutzen Cookies, die für die Funktion dieser Webseite notwendig sind und die den in der Datenschutzerklärung beschriebenen Zwecken dienen. Mit dem Schließen dieses Hinweises oder der weiteren Nutzung dieser Seite stimmen Sie der Datenschutzerklärung und dem Einsatz von Cookies zu. Ok